SCHEMBL25366340

SCHEMBL25366340

COc1ccc(-c2nc3c(C)nc(-c4ccc(N5CCNCC5)cc4)cc3n2C)cc1OC

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ACVR1 Q04771 15/20 0.48
▸ TGFBR1 P36897 13/20 0.48
▸ BMPR1A P36894 2/20 0.46
▸ ACVRL1 P37023 2/20 0.46
▸ RIPK2 O43353 1/20 0.46
▸ MAP4K1 Q92918 2/20 0.46
▸ IL2 P60568 1/20 0.46
▸ ACVR1B P36896 5/20 0.45
▸ KCNH2 Q12809 3/20 0.45
▸ BMPR1B O00238 1/20 0.45
▸ ABL1 P00519 1/20 0.45
▸ ADRA2A P08913 1/20 0.45
▸ CNR1 P21554 1/20 0.45
▸ DDR1 Q08345 1/20 0.45
▸ PTK6 Q13882 1/20 0.45
▸ MINK1 Q8N4C8 1/20 0.45
▸ SIK2 Q9H0K1 1/20 0.45
▸ MAP3K20 Q9NYL2 1/20 0.45
▸ NLK Q9UBE8 1/20 0.45
▸ TNIK Q9UKE5 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30541655 0.88 MAP4K1 (0.41) ACVR1TGFBR1BMPR1AACVRL1RIPK2
SCHEMBL25365954 0.88 MAP4K1 (0.41) ACVR1TGFBR1BMPR1AACVRL1RIPK2
SCHEMBL30541640 0.86 ACVR1 (0.47) ACVR1TGFBR1BMPR1AACVRL1MAP4K1
SCHEMBL25365763 0.86 ACVR1 (0.47) ACVR1TGFBR1BMPR1AACVRL1MAP4K1
SCHEMBL25363522 0.85 MAP4K1 (0.39) MAP4K1CYP3A4CYP2C9CYP2C19
SCHEMBL30541654 0.85 MAP4K1 (0.39) ACVR1TGFBR1MAP4K1
SCHEMBL25364542 0.85 MAP4K1 (0.39) ACVR1TGFBR1MAP4K1
SCHEMBL25365293 0.84 TLR7 (0.45) MAP4K1KCNH2TLR9TLR8TLR7
SCHEMBL25365416 0.84 TLR9 (0.42) ACVR1TGFBR1MAP4K1TLR9TLR8
SCHEMBL30541587 0.84 TLR9 (0.42) ACVR1TGFBR1MAP4K1TLR9TLR8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023159153-A1 SUBSTITUTED BICYCLIC HETEROARYL COMPOUNDS USEFUL AS INHIBITORS OF TLR9 BRISTOL-MYERS SQUIBB COMPANY (US) 2023-08-24 — — WO disclosed
Send feedback